Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement : Thomas Köhler, Elke Schwier, Dietrich Henzler, Claas Eickmeyer ; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany
Опубликовано в: : | Journal of Critical Care 66(2021)S. 187-188 |
---|---|
Главные авторы: | Köhler, Thomas (Автор), Schwier, Elke (Автор), Henzler, Dietrich (Автор), Eickmeyer, Claas (Автор) |
Формат: | Статья |
Язык: | English |
Опубликовано: |
2021
|
Предметы: | |
Online-ссылка: | https://doi.org/10.1016/j.jcrc.2021.07.011 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314144/ |
Связанные документы: | In:
Journal of Critical Care |
Схожие документы
-
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
по: Schultz, Philipp, и др.
Опубликовано: (2021) -
Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
по: Hawchar, Fatime, и др.
Опубликовано: (2022) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
по: Köhler, Thomas, и др.
Опубликовано: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
по: Köhler, Thomas, и др.
Опубликовано: (2021) -
The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
по: Unterberg, Matthias, и др.
Опубликовано: (2022)